Coya Therapeutics, Inc.
COYA
Last
$4.95
Day
-0.8%
1y
-20.4%
5y
+9.2%
52w
-35.6%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1131d
EMA 21
4.88
EMA 50
4.82
EMA 200
4.93
20d high
-6.7%
5y high
-53.3%
5y range
24th
Positions held
Your positionsCOYA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
28
Hold
swing
Signal
Buy
Target
$5.45
Stop
$4.61
Stop distance
6.9%
Target vs last
+10.1%
Fundamentals
| Market cap | $117.05M | Enterprise value | $73.87M | Trailing P/E | — | Forward P/E | -2.65 |
| PEG | — | Price / book | 2.70 | Beta | 0.58 | Dividend yield | 0.00% |
| Revenue growth | 49.0% | Earnings growth | — | Gross margin | -111.8% | Operating margin | -28.9% |
| Profit margin | -2.7% | ROE | -60.5% | ROA | -32.3% | Debt / equity | — |
| Current ratio | 13.40 | Free cash flow | -$10.94M | Analyst recommendation | strong_buy | Mean target | $15.21 |
| 52w high | $7.75 | 52w low | $3.71 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.2M | $0.3M | $4.0M | $3.6M | $0.2M | — |
| Op margin | -2891.1% | -3042.1% | -152.3% | -68.3% | -3920.5% | — |
| Net income | -$6.6M | -$7.2M | -$5.7M | -$2.1M | -$6.1M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$7.0M | -$7.6M | -$6.0M | -$2.4M | -$6.4M | — |
- Revenue -3% vs prior quarter ($0.2M vs $0.3M).
- Operating margin expanded to -2891.1%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $7.9M | $3.6M | $6.0M | $0.0M | — |
| Op margin | -283.9% | -485.4% | -131.7% | — | — |
| Net income | -$21.2M | -$14.9M | -$8.0M | -$12.2M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$22.6M | -$17.2M | -$7.9M | -$9.8M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsCOYA · daily-5.8% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin